Find information on polysubstance use, polysubstance dependence, and polysubstance abuse diagnosis, including clinical documentation requirements, medical coding guidelines (ICD-10 codes F19.20, F19.90, DSM-5 criteria), and treatment resources for healthcare professionals. Learn about substance use disorder, co-occurring disorders, dual diagnosis, and the impact of multiple substance use on patient care and recovery. Explore best practices for accurate diagnosis and effective treatment strategies for patients with polysubstance use involving alcohol, opioids, stimulants, or other substances.
Also known as
Mental and behavioral disorders due to multiple drug use and use of other psychoactive substances
Covers disorders caused by combined use of multiple substances.
Mental and behavioral disorders due to psychoactive substance use
Includes various substance use disorders like alcohol, opioids, etc.
Problem related to lifestyle
Can be used to indicate a problem with polysubstance use as a lifestyle issue.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is there use of multiple substances?
When to use each related code
| Description |
|---|
| Polysubstance use |
| Opioid Use Disorder |
| Stimulant Use Disorder |
Coding F19.90 lacks specificity, impacting reimbursement and data analysis. CDI should clarify substances used for accurate coding.
Incorrect sequencing of polysubstance use with other conditions can affect DRG assignment and payment. Thorough documentation is crucial.
Using multiple substance use codes when a combination code (F19.-) exists can lead to overcoding and compliance issues.
Patient presents with polysubstance dependence, exhibiting a problematic pattern of polysubstance use leading to clinically significant impairment or distress, as manifested by at least two of the following criteria within a 12-month period: Impaired control over substance use (e.g., taking larger amounts or over a longer period than intended; persistent desire or unsuccessful efforts to cut down or control use; significant time spent obtaining, using, or recovering from substance use; craving). Social impairment (e.g., failure to fulfill major role obligations at work, school, or home; continued substance use despite persistent or recurrent social or interpersonal problems caused or exacerbated by its effects; important social, occupational, or recreational activities given up or reduced because of substance use). Risky use (e.g., recurrent substance use in situations in which it is physically hazardous; continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance). Pharmacological criteria (e.g., tolerance, as defined by either a need for markedly increased amounts of the substance to achieve intoxication or desired effect, or markedly diminished effect with continued use of the same amount; withdrawal, as manifested by either the characteristic withdrawal syndrome for the substance, or the same or a closely related substance is taken to relieve or avoid withdrawal symptoms). Substances involved include (list substances). Differential diagnoses considered include substance-induced disorders, mood disorders, anxiety disorders, and personality disorders. Treatment plan includes referral to addiction specialist for further evaluation and management, consideration for medication-assisted treatment, individual therapy focusing on cognitive behavioral therapy and motivational interviewing techniques, and support groups. Patient education provided on risks associated with polysubstance use, relapse prevention strategies, and available community resources. Follow-up scheduled in (timeframe) to monitor progress and adjust treatment plan as needed. Current mental status examination reveals (patient's mental status, including mood, affect, thought processes, and judgment).